Abeona Therapeutics Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (USD $)	Common Stock [Member]	Preferred Stock - A [Member]	Preferred Stock - B [Member]	Additional paid-in capital [Member]	Treasury stock [Member]	Accumulated (deficit) [Member]	Total
Balance at Dec. 31, 2012	$ 247,000	$ 0	$ 0	$ 250,653,000	$ (4,000)	$ (267,972,000)	$ (17,076,000)us-gaap_StockholdersEquity
Balance (in shares) at Dec. 31, 2012	24,732,312	2,913.3617	1,000
Common stock issued for services	2,000	0	0	109,000	0	0	111,000
Common stock issued for services (in shares)	242,631
Common stock issued to directors and employees	5,000	0	0	162,000	0	0	167,000
Common stock issued to directors and employees (in shares)	429,500
Common stock issued for cash exercise of options	1,000	0	0	28,000	0	0	29,000
Common stock issued for cash exercise of options (in shares)	125,000
Preferred stock converted into common stock	2,000	0	0	(2,000)	0	0	0
Preferred stock converted into common stock (in shares)	200,000	(10.0000)
Stock option compensation expense	0	0	0	439,000	0	0	439,000
Preferred dividends	0	0	0	0	0	(2,898,000)	(2,898,000)us-gaap_DividendsPreferredStockCash
Net income (loss)	0	0	0	0	0	4,449,000	4,449,000us-gaap_NetIncomeLoss
Balance at Dec. 31, 2013	6,000	0	0	251,640,000	(4,000)	(266,421,000)	(14,779,000)us-gaap_StockholdersEquity
Balance (in shares) at Dec. 31, 2013	514,589	2,903.3617	1,000
Common stock issued for services	0	0	0	349,000	0	0	349,000
Common stock issued for services (in shares)	22,000						1,096,151
Preferred stock converted into common stock	0	0	0	0	0	0	0
Preferred stock converted into common stock (in shares)	4,000	(10.0000)
Additional adjustments for reverse stock split	0	0	0	0	0	0	0
Additional adjustments for reverse stock split (in shares)	6,609
Cancel treasury stock	0	0	0	(4,000)	4,000	0	0accp_TreasuryStockValueRetired
Cancel treasury stock (in shares)	(3)
Common stock issued for $4.00 share net of costs	35,000	0	0	12,272,000	0	0	12,307,000
Common stock issued for $4.00 share net of costs (in shares)	3,500,000
Common stock issued for Series A preferred stock	72,000	0	0	(72,000)	0	0	0
Common stock issued for Series A preferred stock (in shares)	7,233,404	(2,893.3617)
Common stock issued for Series A preferred stock unpaid dividends and interest	17,000			7,066,000	0	0	7,083,000
Common stock issued for Series A preferred stock unpaid dividends and interest (in shares)	1,728,365
Elimination of derivative liability - preferred stock	0	0	0	24,300,000	0	0	24,300,000
Series B preferred stock issued for unpaid Series B dividends and interest	0	0	0	3,047,000	0	0	3,047,000
Series B preferred stock issued for unpaid Series B dividends and interest (in shares)			304
Series B preferred stock issued for unpaid liquidated damages	0	0	0	857,000	0	0	857,000
Series B preferred stock issued for unpaid liquidated damages (in shares)			86
Common stock issued for Series B preferred stock, unpaid dividends and interest and liquidated damages	70,000		0	(70,000)	0	0	0
Common stock issued for Series B preferred stock, unpaid dividends and interest and liquidated damages (in shares)	6,951,837		(1,390)
Stock option compensation expense	0	0	0	1,305,000	0	0	1,305,000
Preferred dividends	0	0	0	0	0	(2,875,000)	(2,875,000)us-gaap_DividendsPreferredStockCash
Net income (loss)	0	0	0	0	0	(26,778,000)	(26,778,000)us-gaap_NetIncomeLoss
Balance at Dec. 31, 2014	$ 200,000	$ 0	$ 0	$ 300,690,000	$ 0	$ (296,074,000)	$ 4,816,000us-gaap_StockholdersEquity
Balance (in shares) at Dec. 31, 2014	19,960,801	0	0